Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Mitoxantrone × Clear all

NCT00002598 2013-06-25

Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Phase 2 Completed

Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative